CARDINAL HEALTH INC (CAH) — Quarterly Report

AI-Powered SEC Filing Analysis

Latest Quarterly Report Filed: 2026-04-30

Key Insights

Filing contains extensive segment reporting across Pharmaceutical and Specialty Solutions, GMPD, and other segments with multiple acquisitions tracked including Solaris Health, GIA, ADS, ION, and Urology America indicating active M&A activity and portfolio diversification.
Complex organizational structure with variable interest entities and noncontrolling interests suggests Cardinal Health is managing multiple joint ventures and consolidated entities, which could impact transparency and require careful analysis of equity attribution.
Presence of multiple intangible asset categories (customer contracts, trademarks, patents, developed technology rights, noncompete agreements) across acquisitions indicates substantial goodwill that may require impairment testing if operational performance deteriorates.

Want the newest filings?

This analysis covers the filing from 2026-04-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Quarterly Report filings

Filed: 2026-02-05

The company reported a decline in revenue and profitability compared to the prior year period, indicating potential operational challenges.
Cardinal Health faced legal issues related to unspecified lawsuits, which could expose the company to financial and reputational risks.
The company's segment performance was mixed, with the Pharmaceutical and Specialty Solutions segment showing signs of weakness while the GMPD segment performed relatively better.

Other reports for CARDINAL HEALTH INC

Current Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.